— Know what they know.
Not Investment Advice
Also trades as: ACW.AX (ASX) · $vol 0M

ATGGF OTC

Actinogen Medical Limited
1W: +71.4% 1M: +71.4% 3M: +7400.0% YTD: +50.0% 1Y: +140.0% 3Y: +150.0% 5Y: +71.4%
$0.06
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 63 · $223.0M mcap · 3.06B float · 0.011% daily turnover · Short 48% of daily vol

Balance Sheet Trends

Total Assets
$30M +20.6% ▲
5Y CAGR: +9.9%
Total Liabilities
$8M +33.0% ▲
5Y CAGR: +54.8%
Shareholders Equity
$21M +16.4% ▲
5Y CAGR: +4.1%
Cash & Investments
$17M +1.3% ▲
5Y CAGR: +4.5%
Total Debt
$5M +46.3% ▲
5Y CAGR: +82.4%
Net Debt
-$12M +9.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$16M$8M$9M$17M$17M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$16M$8M$9M$17M$17M
Net Receivables$4M$4M$9M$6M$11M
Inventory$0$0$0$0$0
Other Current Assets$0$240K-$109K$0$0
Total Current Assets$20M$13M$19M$22M$28M
Property, Plant & Equip.$169K$113K$341K$270K$173K
Goodwill & Intangibles$3M$2M$2M$2M$1M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$3M$3M$2M$2M$2M
Total Assets$23M$15M$21M$24M$30M
— Liabilities —
Accounts Payable$899K$1M$597K$2M$1M
Short-Term Debt$0$0$0$3M$5M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0-$801K$2M
Total Current Liabilities$1M$2M$1M$6M$8M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$87K$87K$258K$187K$87K
Total Liabilities$2M$2M$2M$6M$8M
— Equity —
Common Stock$77M$79M$100M$101M$138M
Retained Earnings-$58M-$69M-$82M-$96M-$112M
Accumulated OCI$9M$11M$1M$14M$15M
Total Stockholders Equity$22M$13M$20M$18M$21M
Total Liabilities & Equity$23M$15M$21M$24M$30M
— Key Metrics —
Total Debt$165K$87K$319K$3M$5M
Net Debt-$16M-$8M-$9M-$13M-$12M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms